Skip to main content
Equibles
KMTS logo

KMTS · Kestra Medical Technologies, Ltd. · Metrics

Track KMTS — free

Use KMTS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.23 -0.31 (-1.21%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.50B
Shares
58.60M

KMTS metrics

68 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.54
Market cap
$1.50B

Price action

19 metrics
Price change (1W)
-0.4%
Price change (30D)
-9.9%
Price change (3M)
+31.6%
Price change (6M)
+10.9%
Price change (YTD)
-3.7%
Price change (1Y)
+54.7%
Trailing year
Price change (5Y)
—
52-week high
$28.35
52-week low
$16.51
Change from 52-week high
-9.9%
Change from 52-week low
+54.7%
Annualized volatility
64.5%
Beta
1.7
RSI (14D)
47.7
Price vs SMA 50
+0.1%
Price vs SMA 200
+8.3%
Avg volume (3M)
357,486
Relative volume
0.5
Average dollar volume
$8.82M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
58.60M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
14.1×
reciprocal yield 7.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
15.7×
reciprocal yield 6.4%
P / book
5.8
reciprocal yield 17.3%
FCF yield
-7.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-14

Profitability

9 metrics
Gross margin
51.4%
Operating margin
-141.6%
Trailing 12 months
Net margin
-138.4%
Gross profit (TTM)
$48.86M
Operating profit (TTM)
−$134.74M
Net income (TTM)
−$131.61M
Trailing 12 months
Diluted EPS (TTM)
$-2.43
FCF margin
-122.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1,978.84

Growth

11 metrics
Revenue growth YoY
+66.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$95.13M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+180.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-50.7%
Return on assets
-36.7%
Debt / equity
0.2
Current ratio
4.4
EBITDA (TTM)
−$126.03M
Free cash flow (TTM)
−$116.59M
Quick ratio
4.4
Interest coverage
-17.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$153.78M
Latest balance sheet
Cash & equivalents
$99.71M
Total assets
$358.46M
Total debt
$42.65M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$81.70M
Capital expenditures (TTM)
$34.89M
R&D (TTM)
$19.48M
SG&A (TTM)
$164.12M
Stock compensation (TTM)
$33.64M
R&D / revenue
20.5%
Stock compensation / revenue
35.4%

Ownership (13F)

3 metrics
13F filers
109
13F filer change QoQ
+6
Institutional ownership
100.2%

Short interest

3 metrics
Short interest
5.1%
Latest settlement · 9.0 days to cover
Days to cover
9.0d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.04M
Insider-sentiment score
11 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1877184 CUSIP G52441105 13F (30d) 78 filings 78 filers Visit website Investor relations